Phase 1 Study Of Intrathecal Cellular Adoptive Immunotherapy Using Autologous CD8+ Antigen-Specific T Cells For Patients With Leptomeningeal Melanoma
Clinical trial NCT07414979 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07414979
- Sponsor
- M.D. Anderson Cancer Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-31
- Primary completion
- 2028-03-22
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.